Search research articles
Contact Us
Filters
Showing results (241-250 of 368) with videos related to
Page
of 37
Sort By:
Cancer
|
September 15, 1989
Cell kinetics in ovarian cancer. Relationship to clinicopathologic features, responsiveness to chemotherapy, and survival
P F Conte, A Alama, A Rubagotti, et al.
Critical Reviews in Oncology/Hematology
|
February 13, 2001
Advanced ovarian cancer in the elderly: results of consecutive trials with cisplatin-based chemotherapy
S Chiara, R Lionetto, M Vincenti, et al.
Breast Cancer Research and Treatment
|
January 1, 1996
Tamoxifen and interferon-beta for the treatment of metastatic breast cancer
L Repetto, P G Giannessi, E Campora, et al.
Seminars in Oncology
|
October 1, 1996
A dose-finding study of epirubicin in combination with paclitaxel in the treatment of advanced breast cancer
P F Conte, A Michelotti, E Baldini, et al.
Nephron
|
January 1, 1988
Thrombolysis in myocardial infarction and double aortocoronary bypass in a patient on continuous ambulatory peritoneal dialysis
A Volpi, M Bertella, A Tommasi, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy
|
June 1, 1986
A phase II study of mitoxantrone in advanced breast cancer
P Pronzato, A Ardizzoni, P F Conte, et al.
Giornale Italiano Di Chemioterapia
|
January 1, 1985
[Second instance chemotherapy with high-dose cisplatin in patients with advanced ovarian neoplasms in progression or recurrence after treatment with cisplatin]
M Bruzzone, P F Conte, S Chiara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 1999
Cardiotoxicity of epirubicin/paclitaxel-containing regimens: role of cardiac risk factors
A Gennari, B Salvadori, S Donati, et al.
The Journal of Urology
|
August 1, 1996
The effect of prepubertal androgen exposure on adult penile length
R S Sutherland, B A Kogan, L S Baskin, et al.
Breast Cancer Research and Treatment
|
July 1, 1988
Cisplatin and 5-fluorouracil in refractory breast cancer patients: a phase II study
D Amoroso, P Pronzato, G Bertelli, et al.
Page
of 37
Search research articles
Search
Showing results (241-250 of 368) with videos related to
Sort By:
Page
of 37
Cancer
|
September 15, 1989
Cell kinetics in ovarian cancer. Relationship to clinicopathologic features, responsiveness to chemotherapy, and survival
P F Conte, A Alama, A Rubagotti, et al.
Critical Reviews in Oncology/Hematology
|
February 13, 2001
Advanced ovarian cancer in the elderly: results of consecutive trials with cisplatin-based chemotherapy
S Chiara, R Lionetto, M Vincenti, et al.
Breast Cancer Research and Treatment
|
January 1, 1996
Tamoxifen and interferon-beta for the treatment of metastatic breast cancer
L Repetto, P G Giannessi, E Campora, et al.
Seminars in Oncology
|
October 1, 1996
A dose-finding study of epirubicin in combination with paclitaxel in the treatment of advanced breast cancer
P F Conte, A Michelotti, E Baldini, et al.
Nephron
|
January 1, 1988
Thrombolysis in myocardial infarction and double aortocoronary bypass in a patient on continuous ambulatory peritoneal dialysis
A Volpi, M Bertella, A Tommasi, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy
|
June 1, 1986
A phase II study of mitoxantrone in advanced breast cancer
P Pronzato, A Ardizzoni, P F Conte, et al.
Giornale Italiano Di Chemioterapia
|
January 1, 1985
[Second instance chemotherapy with high-dose cisplatin in patients with advanced ovarian neoplasms in progression or recurrence after treatment with cisplatin]
M Bruzzone, P F Conte, S Chiara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 1999
Cardiotoxicity of epirubicin/paclitaxel-containing regimens: role of cardiac risk factors
A Gennari, B Salvadori, S Donati, et al.
The Journal of Urology
|
August 1, 1996
The effect of prepubertal androgen exposure on adult penile length
R S Sutherland, B A Kogan, L S Baskin, et al.
Breast Cancer Research and Treatment
|
July 1, 1988
Cisplatin and 5-fluorouracil in refractory breast cancer patients: a phase II study
D Amoroso, P Pronzato, G Bertelli, et al.
Page
of 37